Filter
1843
Filtered Results: 1843
Text search:
medicine
prices
Featured
Recommendations
165
New Publications
502
Language
Document type
No document type
964
Studies & Reports
442
Guidelines
203
Strategic & Response Plan
90
Manuals
77
Fact sheets
24
Situation Updates
18
Training Material
14
Resource Platforms
6
Infographics
3
Brochures
2
Countries / Regions
Global
89
India
59
Kenya
48
Uganda
42
South Africa
40
Nepal
39
Ukraine
39
Syria
37
Ethiopia
35
Africa
34
Liberia
32
Sierra Leone
30
Nigeria
29
Western and Central Europe
29
Malawi
25
Zambia
25
Myanmar / Burma
25
Bangladesh
24
Latin America and the Carribbean
23
Congo, Democratic Republic of
20
Ghana
19
Rwanda
18
Tanzania
18
Zimbabwe
16
Philippines
16
Mozambique
15
Venezuela
14
Eastern Europe
14
South–East Asia Region
13
Namibia
13
South Sudan
13
Cameroon
12
Haiti
12
Guinea
11
Cambodia
11
Senegal
10
Asia
10
Burkina Faso
9
Sudan
9
Yemen
9
Indonesia
9
Germany
8
Brazil
8
Russia
8
Pakistan
8
Benin
7
West and Central Africa
7
Middle East and North Africa
7
Moldova
7
Botswana
7
Tajikistan
6
Lesotho
6
East and Southern Africa
6
Lebanon
6
Central African Republic
6
Thailand
5
North America
5
Albania
4
Kyrgyzstan
4
Afghanistan
4
Peru
4
USA
4
Eastern Europe and Central Asia
4
Paraguay
4
Eswatini/ Swaziland
4
Colombia
3
Kazakhstan
3
Chile
3
Jordan
3
Vietnam
3
Georgia
3
Mali
3
Somalia
3
North Macedonia
2
Turkey
2
China
2
Laos
2
Turkmenistan
2
Jamaica
2
Portugal
2
Spain
2
Bosnia and Herzegovina
2
Southern Africa
2
Argentina
2
Papua New Guinea
2
Egypt
2
Romania
2
Palestine
2
Poland
2
Angola
2
Chad
2
Timor Leste/ East Timor
1
El Salvador
1
Serbia
1
Iran
1
Fiji
1
Estonia
1
Niger
1
Mongolia
1
Bulgaria
1
Lithuania
1
Western Pacific Region
1
Gabon
1
Japan
1
Denmark
1
France
1
Mauritius
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Sri Lanka
1
Libya
1
Bhutan
1
Ecuador
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
701
Clinical Guidelines
157
Public Health
122
Women & Child Health
67
Key Resources
56
Pharmacy & Technologies
33
Capacity Building
8
Toolboxes
HIV
180
COVID-19
157
Mental Health
133
Pharmacy
102
AMR
81
TB
79
Conflict
74
Planetary Health
62
NCDs
55
Global Health Education
43
Disability
32
Health Financing Toolbox
31
Ebola
28
Rapid Response
27
NTDs
27
Natural Hazards
26
Refugee
25
Caregiver
25
Cholera
4
Specific Hazards
3
Social Ethics
3
Health Financing
1
Zika
1
Polio
1
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t...
The COVID-19 pandemic has resulted in a double shock - health and economic. As of March 1, 2021, COVID-19 has cost more than 2.5 million lives and triggered an economic recession surpassing any economic downturn since World War II.
Part I of this paper explores the impact of this current macro-fisc...
The majority of developing countries will fail to achieve their targets for Universal Health Coverage (UHC)1 and the health- and poverty-related Sustainable Development Goals (SDGs) unless they take urgent steps to strengthen their health financing. Just over a decade out from the SDG deadline of 20...
The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i...
The ongoing COVID-19 pandemic has shown that public financial management (PFM) should be an integral part of the response. Effectiveness in financing the health response depends not only on the level of funding but also on the way public funds are allocated and spent, this is determined by the PFM r...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T...
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively. ...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Humanitarian crises exacerbate nutritional risks and often lead to an increase in acute malnutrition. Emergencies include both manmade (conflict) and natural disasters (floods, drought, cyclones, typhoons, earthquakes, volcanic eruptions, etc.). Complex emergencies are combinations of both manmade a...
The Resolution Population and Individual Approaches to the Prevention and Management of Diabetes and Obesity was approved by the 48th Directing Council of the Pan American Health Organization, September 29- October 3, 2008, in response to the epidemic of obesity and diabetes currently affecting the ...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria targets. The strategy outlines 4 strategic objectives ...
Obesity and diabetes are affecting the peoples of the Americas at high and increasing rates. National surveys demonstrate that obesity is increasing in prevalence among all age groups; 7% to 12% of children under 5 years old and
one-fi fth of adolescents are obese, while rates of overweight and obe...
The Public Health Burden of Commercial Tobacco Use
The burden of disease and death from commercial tobacco* use in the United States is
overwhelmingly caused by cigarettes and other combustible tobacco products.
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a comprehensive strategy to address the global rise in noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, chronic respiratory diseases,...
One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of the area to which the plan will apply. This will help countries, regions, provinces or cities intendi...
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where the world wants to be in terms of NCD prevention a...
The article "Under- and over-diagnosis of COPD: a global perspective" reviews the worldwide variation in the prevalence of chronic obstructive pulmonary disease (COPD) and issues related to its misdiagnosis. It highlights that COPD is under-diagnosed due to factors such as limited access to spiromet...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
